FES

You have access
¹⁸F-Fluoroestradiol PET/CT for Predicting Benefit from Endocrine Therapy in Patients with Estrogen Receptor–Positive Breast Cancer: A Systematic Review and Metaanalysis
Ashwin Singh Parihar, Sofia Vaz, Siobhan Sutcliffe, Niharika Pant, Jan W. Schoones and Gary A. Ulaner

Journal of Nuclear Medicine May 1, 2025, 66 (5) 692-699; DOI: https://doi.org/10.2967/jnumed.124.269163
You have access
The Current and Future Roles of Precision Oncology in Advanced Breast Cancer
Heather Jacene, Eric Dietsche and Jennifer Specht

Journal of Nuclear Medicine March 1, 2024, 65 (3) 349-356; DOI: https://doi.org/10.2967/jnumed.122.264882
You have access
¹⁸F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2− Metastatic Breast Cancer
Lanell M. Peterson, Brenda F. Kurland, Fengting Yan, Alena Novakova- Jiresova, Vijayakrishna K. Gadi, Jennifer M. Specht, Julie R. Gralow, Erin K. Schubert, Jeanne M. Link, Kenneth A. Krohn, Janet F. Eary, David A. Mankoff and Hannah M. Linden

Journal of Nuclear Medicine February 1, 2021, 62 (2) 184-190; DOI: https://doi.org/10.2967/jnumed.120.244459

Main menu